Eyenovia, Inc.

Eyenovia, Inc. is a publicly traded eye care company focused on developing topical ophthalmic therapies that are easier to use and easier to live with. Their flagship product, the Optejet, is the only FDA-approved ophthalmic spray alternative to eye drops. Eyenovia aims to revolutionize the way eye medications are administered, offering a more convenient and effective solution for patients.

The company's pipeline includes MicroPine, a proprietary drug-device combination for the prevention of myopia progression in children, as well as several other dry eye disease treatments. The Optejet's ease of use and potential for digital monitoring through Optecare™ could significantly improve patient compliance and adherence to medication regimens. Eyenovia's mission is to improve the lives of patients by providing innovative, patient-centric solutions for common eye conditions.

Eyenovia does not have any open job positions listed on its website. Therefore, there is no information available about their job flexibility.

Eyenovia is a publicly traded eye care company dedicated to developing and commercializing topical ophthalmic therapies that are easier to use and easier to live with. Their flagship product, the Optejet®, is an FDA-approved ophthalmic spray that provides an alternative to traditional eye drops, offering improved medication delivery and patient compliance. Eyenovia's vision is to improve the lives of patients by providing innovative, effective, and user-friendly eye care solutions.

Eyenovia promotes a culture of innovation and collaboration, driven by a mission to improve eye care through easier-to-use and more effective ophthalmic therapies. They value a diverse and inclusive team, emphasizing the contributions of each individual. Their commitment to ethical practices and high standards of corporate governance underscores a focus on responsibility and integrity.